These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 34532949

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP.
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hydroxyurea in children with sickle cell disease in a resource-poor setting: Monitoring and effects of therapy. A practical perspective.
    Nnebe-Agumadu U, Adebayo I, Erigbuem I, James E, Kumode E, Nnodu O, Adekile A.
    Pediatr Blood Cancer; 2021 Jun; 68(6):e28969. PubMed ID: 33788390
    [Abstract] [Full Text] [Related]

  • 5. Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy.
    Ware RE, Eggleston B, Redding-Lallinger R, Wang WC, Smith-Whitley K, Daeschner C, Gee B, Styles LA, Helms RW, Kinney TR, Ohene-Frempong K.
    Blood; 2002 Jan 01; 99(1):10-4. PubMed ID: 11756146
    [Abstract] [Full Text] [Related]

  • 6. Ten-year longitudinal analysis of hydroxyurea implementation in a pediatric sickle cell program.
    Phan V, Park JA, Dulman R, Lewis A, Briere N, Notarangelo B, Yang E.
    Eur J Haematol; 2022 Nov 01; 109(5):465-473. PubMed ID: 35811388
    [Abstract] [Full Text] [Related]

  • 7. Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia.
    Vicari P, Barretto de Mello A, Figueiredo MS.
    Am J Hematol; 2005 Mar 01; 78(3):243-4. PubMed ID: 15726590
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.
    Charache S.
    Semin Hematol; 1997 Jul 01; 34(3 Suppl 3):15-21. PubMed ID: 9317197
    [Abstract] [Full Text] [Related]

  • 9. Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
    Sumoza A, de Bisotti R, Sumoza D, Fairbanks V.
    Am J Hematol; 2002 Nov 01; 71(3):161-5. PubMed ID: 12410569
    [Abstract] [Full Text] [Related]

  • 10. Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy.
    Borba R, Lima CS, Grotto HZ.
    J Clin Lab Anal; 2003 Nov 01; 17(2):66-72. PubMed ID: 12640630
    [Abstract] [Full Text] [Related]

  • 11. Alpha-thalassaemia and response to hydroxyurea in sickle cell anaemia.
    Darbari DS, Nouraie M, Taylor JG, Brugnara C, Castro O, Ballas SK.
    Eur J Haematol; 2014 Apr 01; 92(4):341-5. PubMed ID: 24330217
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a cohort of Angolan children with sickle cell anemia treated with hydroxyurea.
    Santos B, Ginete C, Gonçalves E, Delgadinho M, Miranda A, Faustino P, Arez AP, Brito M.
    Blood Cells Mol Dis; 2024 Mar 01; 105():102822. PubMed ID: 38215581
    [Abstract] [Full Text] [Related]

  • 13. Minimal doses of hydroxyurea for sickle cell disease.
    Lima CS, Arruda VR, Costa FF, Saad ST.
    Braz J Med Biol Res; 1997 Aug 01; 30(8):933-40. PubMed ID: 9361721
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sickle cell anemia with systemic lupus erythematosus: response to hydroxyurea therapy.
    Shetty AK, Kumar SR, Gedalia A, Warrier RP.
    J Pediatr Hematol Oncol; 1998 Aug 01; 20(4):335-7. PubMed ID: 9703008
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle-cell disease.
    Creary SE, Gladwin MT, Byrne M, Hildesheim M, Krishnamurti L.
    Pediatr Blood Cancer; 2014 Jun 01; 61(6):1068-73. PubMed ID: 24436121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.